Bioxel Pharma: Results For The Second Quarter Of 2006

Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients and developer of targeted oncology drugs, today announced its results for the second quarter ended June 30, 2006.

MORE ON THIS TOPIC